Laurantis Pharma

About:

Laurantis Pharma develops therapeutics for medical niche indications in the dermatology, ophthalmology, and oncology sectors.

Website: http://www.laurantis.com

Top Investors: Broadview Ventures, Inveni Capital

Description:

Laurantis Pharma Oy is a specialty pharmaceutical development company with a broad, clinical-stage portfolio in three therapeutic areas: dermatology, ophthalmology, and oncology. Using two proprietary technologies, Laurantis is developing first-in-class products for commercially and medically significant niche indications in these areas. Laurantis was formed in December 2010 through a merger of the Finnish drug development companies Oy Lx Therapies Ltd and BioCis Pharma Oy.